Results 201 to 210 of about 3,802,616 (346)

THE NATURAL-SELECTION THEORY OF ANTIBODY FORMATION

, 1955
N. K. Jerne
openalex   +1 more source

Antibody in Lymphocytes from Hyperimmunized Rabbits [PDF]

, 1951
Allan J. Erslev
openalex   +1 more source

A bioinformatics screen identifies TCF19 as an aggressiveness‐sustaining gene in prostate cancer

Molecular Oncology, EarlyView.
Gene expression meta‐analysis in multiple prostate cancer patient cohorts identifies Transcription factor 19 (TCF19) as an aggressiveness‐sustaining gene with prognostic potential. TCF19 is a gene repressed by androgen signaling that sustains core cancer‐related processes such as vascular permeability or tumor growth and metastasis.
Amaia Ercilla, Jana R. Crespo, Saioa Garcia‐Longarte, Marta Fidalgo, Sara del Palacio, Natalia Martin‐Martin, Onintza Carlevaris, Ianire Astobiza, Sonia Fernández‐Ruiz, Marc Guiu, Laura Bárcena, Isabel Mendizabal, Ana M. Aransay, Mariona Graupera, Roger R. Gomis, Arkaitz Carracedo   +15 more
wiley   +1 more source

Predictive Value of Classical and Emerging Autoantibodies for Cardiac Dysfunction in Systemic Sclerosis: Systematic Review. [PDF]

J Clin Med
Radić M, Bečić T, Šimac P, Đogaš H, Jukić I, Fabijanić D, Radić J.   +6 more
europepmc   +1 more source

Neutralizing Antibodies Against Certain Viruses in the Sera of Residents of India

, 1954
K. C. Smithburn, J. A. Kerr, P. B. Gatne
openalex   +1 more source

The Production of Antibodies (2nd Edition) [PDF]

, 1951

openalex   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Secretory IgA Is a Key Marker Among Gut Barrier Dysfunction-Related Immunoglobulins Predicting Outcomes in ACLF. [PDF]

Liver Int
Balogh B, Tornai D, Csillag A, Tornai I, Vitalis Z, Kovats P, Antal-Szalmas P, Dinya T, Laleman W, Coenraad MJ, Trebicka J, Papp M, MICROB‐PREDICT and PREDICT study group of the EASL‐CLIF consortium.   +12 more
europepmc   +1 more source

Studies of Blood Group Antibodies [PDF]

, 1959
Neva M. Abelson, Arnold J. Rawson
openalex   +1 more source

Multi‐omic profiling of squamous cell lung cancer identifies metabolites and related genes associated with squamous cell carcinoma

Molecular Oncology, EarlyView.
Using multi‐omic characterization, we aimed to identify key regulators specific to squamous cell lung carcinoma (SqCC). SqCC‐specific differentially expressed genes were integrated with metabolics data. High expression of the creatine transporter SLC6A8, along with elevated creatine levels, appeared to be a distinct metabolic feature of SqCC.
Johan Staaf, Daniel Ehinger, Hans Brunnström, Mats Jönsson, Frida Rosengren, Marija Kotevska, Anna Karlsson, Mattias Aine, Christian Frezza, Maria Planck, Elsa Arbajian   +10 more
wiley   +1 more source